Riyadh Pharma’s Post

A remarkable turnaround for Pharmaniaga Berhad! The Group reported a PAT of RM101.3 million in Q3 FY2024, marking a significant recovery from last year’s loss. Key milestones include the launch of Malaysia’s first locally-owned insulin and vaccine facility and regulatory approval for its recombinant insulin product. These achievements, combined with strong revenue growth and strategic funding, highlight Pharmaniaga’s commitment to advancing healthcare and driving sustainable growth. Press Release: https://lnkd.in/gqYx_p3i Bursa Announcement: https://lnkd.in/gv327SwW  

Great news for Saudi Healthcare! AVALON Pharma, a leading local player, has partnered with Al-Dawaa Medical Services Co. (DMSCO) to manufacture essential medications. This collaboration aims to create a secure and affordable #supplychain for Saudi patients. By producing drugs locally, the agreement reduces dependence on external sources and minimizes medication shortages. Additionally, Avalon Pharma and DMSCO prioritize offering high-quality medications at competitive prices, making them more accessible for citizens. This initiative not only strengthens Saudi Arabia's healthcare infrastructure but also contributes to the nation's #economicdevelopment through job creation. Avalon Pharma sees this as a crucial step towards a more secure and prosperous healthcare system for Saudi Arabia. What can other countries do to encourage local drug manufacturing? Let's discuss! #SaudiArabia #AvalonPharma #DMSCO #SaudiVision2030 #PatientAccess #Localization #LocalManufacturing #AffordableDrugs #CompetitivePricing #HealthcareInfrastructure #SaudiArabia #GulfCountruies #MENA #RASLifeScienceSolutions #MarketIntelligence #MarketResearch #CompetitiveIntelligence #StrategySupport #PortfolioOptimization #MarketExpansion #PartnerIdentification Detailed News: https://lnkd.in/dHk2jYxW Follow our page for more industry updates: https://lnkd.in/de5zNWmK

🔗 Continuing the Conversation: The Role of Supply Chain Dynamics in Pharmacy 🔗 Building on our previous discussion about the importance of supply chain management in pharmacy, let’s delve deeper into how specific companies navigate these challenges. 🌍💊 Example 1: Novartis Novartis faces significant bargaining power from large healthcare providers and pharmacy benefit managers (PBMs). These entities can negotiate substantial discounts on medications like Cosentyx, which impacts not only pricing but also patient access to essential treatments. As pharmacists, being aware of these negotiations allows us to better understand the availability of certain medications and advocate effectively for our patients. Example 2: Al Nahdi Group As a leading pharmacy chain in Saudi Arabia, Al Nahdi Group exemplifies how buyer power can shape market dynamics. Their ability to negotiate favorable terms with pharmaceutical manufacturers influences which products are stocked and promoted in their pharmacies. This not only affects pricing but also the variety of medications available to patients, making it crucial for pharmacists to stay informed about these trends. 🌟 Why This Matters By understanding how companies like Novartis and Al Nahdi navigate supply chain complexities, we can enhance our practice. Knowledge of these dynamics empowers us to advocate for fair pricing, improve medication access, and ultimately enhance patient outcomes. Let’s continue to embrace the power of supply chain management in our profession! Together, we can make a difference in patient care. #Pharmacy #SupplyChainManagement #Novartis #AlNahdiGroup #PatientAdvocacy #Healthcare

Transforming Healthcare: Saudi Arabia’s Vision 2030 and the Pharmaceutical Landscape As part of Saudi Arabia's ambitious Vision 2030, the healthcare sector is undergoing a remarkable transformation aimed at enhancing the quality of care, increasing accessibility, and fostering innovation. Here’s a closer look at how this vision shapes the pharmaceutical industry: 1. Vision 2030 Overview** - Aiming to diversify the economy and reduce reliance on oil. - Focusing on improving healthcare services and infrastructure. 2. Goals for the Healthcare Sector** - **Accessibility**: Ensuring all citizens have access to quality healthcare. - **Quality Improvement**: Elevating the standards of healthcare services. - **Technological Integration**: Embracing digital health solutions and telemedicine. 3. Focus on the Pharmaceutical Industry** - **Local Manufacturing**: Reducing dependency on imports by boosting local production. - **R&D Investments**: Encouraging innovation through research and development initiatives. - **Regulatory Reforms**: Streamlining processes to facilitate market entry for new drugs. 4. Challenges Ahead** - Addressing the current reliance on imported pharmaceuticals. - Enhancing local capacity for advanced drug development and manufacturing. - Navigating regulatory complexities for both local and international players. 5. Opportunities for Growth** - Collaborations between public and private sectors to drive innovation. - Establishing a supportive ecosystem for startups and emerging companies in pharma. - Aligning strategies with global trends in healthcare and pharmaceuticals. 🚀 **Conclusion**: As Saudi Arabia embarks on this transformative journey, the pharmaceutical industry stands at the forefront of change. By embracing innovation and fostering collaboration, we can create a sustainable healthcare ecosystem that meets the needs of the Kingdom and beyond. 🔗 Let’s discuss how we can all contribute to this exciting transformation! #SaudiVision2030 #Healthcare #Pharmaceuticals #Innovation #R&D

Discover our #HikmaFootprint. For over 30 years, Hikma #Algeria has been supporting healthcare needs of patients in the country with a diversified portfolio of medicines covering eight therapeutic areas to address a wide range of healthcare needs. Operating four manufacturing plants we are investing in building more local capabilities to continue to improve access to essential medicine. We leverage our extensive high-quality manufacturing capabilities to supply medicines and make a meaningful impact in the local communities we serve. Read more: https://lnkd.in/dC7_Dp4B #PharmaceuticalManufacturing #LocalExpertiseGlobalReach #MENA

Thank you to the esteemed industry leaders and experts – Alaa Darwish, Dr Srikanth Rajagopal, Mohamed Amir, Firat Incioglu, Rina Chotai, and Hasan Kapar – for joining us at the Waldorf Astoria DIFC in Dubai for a thought-provoking roundtable discussion on "Unlocking the Market: Strategies for Pharmaceutical Pricing, Access, and Tenders in the GCC" earlier this month. The event provided a valuable platform to examine the critical role of national tenders in improving access to safe and effective medicines across the region. Experts engaged in an insightful dialogue on the current state of tender practices, delving into the evolution of these systems and their impact on the pharmaceutical industry, particularly in relation to various drug types. The conversation also focused on identifying key principles and best practices for designing a national tender system that ensures fair pricing, accessibility, and operational efficiency. Stay tuned for a report highlighting the key discussion topics and emerging trends. Discover more about Clarivate’s market-leading intelligence and transformative data technology here: https://lnkd.in/gD-vvkum #Pharmaceuticals #MarketAccess #Healthcare #Tenders #PharmaStrategy #HealthcareInnovation #Dubai

Monique Mantovani shared invaluable insights during the panel session "Key Note: Unveiling the Keys to Local Production in LatAm" at Biosimilars LatAm - Colombia 2024. She emphasized the importance of dialogue with local regulatory agencies like #ANVISA, highlighting how such discussions can streamline the #biosimilar registration process and pave the way for local production. 🌟💬 Let's continue fostering these partnerships to streamline biosimilar registrations and enhance healthcare accessibility. LIBBS FARMACÊUTICA LTDA #BiosimilarsLatAm #Colombia2024 #HealthcareRegulation #CollaborativeEfforts #RegulatoryDialogue #LocalProduction

It is an interesting time to be in the Middle East and, nearly on a daily basis, I hear about the exciting energy coming from Saudi Arabia when it comes to Healthcare and Life Sciences. Saudi Arabia is set to revolutionize its healthcare and pharmaceutical sectors, embracing innovation and sustainability. Here's how: 🚀 Vision 2030 is Propelling Saudi Arabia: the Kingdom aims to provide inclusive health services and integrate a digital medical records system by 2025. 🌍 MENA’s Pharmaceutical Powerhouse: As the largest pharmaceutical market in the region providing accelerated regulatory pathways and innovative pricing mechanisms such as value-based contracting, the Kingdom sparks interest in many MNCs. 📈 Local Manufacturing on the Rise: the Saudi government targets to localize 40% of the pharmaceutical sector, addressing both biologics and generics needs internally. 🚑 Universal Health Coverage Goals: with a growing elderly population and increase of NCDs, the initiative is a proactive approach to expand access to essential healthcare services. How do you think things will evolve in the near future? #ksa #pharmaceuticals #pharma #innovation #healthcare #accesstocare #LifeSciences

AfriSummit 2024: Harmonizing Health Through Unified Regulations and Pharma Innovation On November 6th, 2024, AfriSummit 2024 brought together over 300 professionals from the pharmaceutical and medical device industries and 80 international experts at the Grand Nile Tower. Hosted by PharmaReg and MedDevReg, the four-day hybrid event emphasized Africa’s commitment to harmonizing healthcare regulations and fostering innovation in drug trials and regulatory practices. Key Highlights: ▪️ Hands-on Training: Workshops focused on eCTD and Pharmacovigilance emphasized practical skills for compliance and innovation. ▪️ Leadership in Action: Dr. Rasha Ziada of the Egyptian Drug Authority (EDA) stressed the responsibility of achieving WHO Maturity Level 3, extending EDA's regulatory expertise to support other African nations. ▪️ Collaborative Solutions: Roundtable discussions united African National Regulatory Authorities (NRAs) with industry leaders, identifying opportunities to strengthen healthcare regulations across the continent. ▪️ Calls for Harmonization: Dr. Mona Al Moussli, Chairman of AfriSummit, highlighted the urgent need for unified regulatory frameworks, declaring, “Harmonized practices are key to advancing Africa’s healthcare systems.” At VICORE HEALTH LTD, whilst we could unfortunately not attend, we support and align with these transformative efforts, while offering expertise in navigating regulatory landscapes and fostering innovation in healthcare. Manufacturers seeking to adapt to Africa’s evolving regulatory environment are encouraged to connect with us for tailored solutions. https://lnkd.in/ewr9iAEB #AfriSummit2024 #HealthcareInnovation #RegulatoryHarmonization #PharmaAfrica #VicoreHealth

Did you know that all delegates who are registered to attend the SAPICS 2024 conference can book a seat at a workshop of their choice on Sunday the 9th of June?   Tamara Hafner and Dr Andrew Brown will be presenting Workshop 8: The Nexus of Pharmaceutical Systems and Health Supply Chain Management. What is Needed to Ensure well-functioning supply chains?   Sustainably ensuring equitable access to and appropriate use of safe and quality-assured medicines demands a comprehensive view that situates health supply chains within strong pharmaceutical systems, as a part of the broader health system. USAID MTaPS and its predecessor programs have developed a pharmaceutical system strengthening (PSS) approach that recognizes health supply chains as one of several elements that work in concert to get safe, quality-assured medicines to the population and ensure that they are used appropriately. Participants will learn about the PSS approach and available tools and resources that they can adapt in their health system context.   Learn more about all 11 workshop workshops on offer: https://lnkd.in/dv3_W8yC   The 2024 SAPICS Conference will be held in association with the Southern African Association of Freight Forwarders NPC In view of the demand for workshop attendance and the unfortunate rate of no-shows, there is a non-refundable charge of R350.00 (excl. VAT) per person per workshop. Organised by: Upavon Management Taking place at Century City Conference Centre, Cape Town, South Africa  #SAPICS2024 #SupplyChainMetamorphosis #SupplyChainConference #CapeTown #supplychainmanagement #speakers